Abivax SA American Depositary Shares

Stock Chart, Company Information, and Scan Results

$93.78(as of Oct 10, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Abivax SA American Depositary Shares Company Information, Fundamentals, and Technical Indicators

Stock Price$93.78
Ticker SymbolABVX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees69
CountyUSA
Market Cap$7,298.0M

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Abivax SA American Depositary Shares In Our Stock Scanner

As of Oct 13, 2025
As of ---
As of ---
As of ---
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.